155 related articles for article (PubMed ID: 10545732)
1. Chronic cholestasis associated with Turner's syndrome.
Floreani A; Molaro M; Baragiotta A; Naccarato R
Digestion; 1999; 60(6):587-9. PubMed ID: 10545732
[TBL] [Abstract][Full Text] [Related]
2. [A case of cholangiocarcinoma and dysgerminoma associated with Turner's syndrome].
Ishiyama S; Makuuchi M; Ohta K; Yamazaki S; Hasegawa H; Watanabe S; Takayasu K; Moriyama N
Gan No Rinsho; 1986 Apr; 32(4):433-9. PubMed ID: 3012144
[TBL] [Abstract][Full Text] [Related]
3. [Chronic asymptomatic intrahepatic cholestasis associated with Turner's syndrome].
Andrade RJ; Alcántara R; Fraile JM; Lazo MD; Llamas A; Carmona C; Franquelo E
Gastroenterol Hepatol; 1995; 18(7):375-8. PubMed ID: 7553275
[TBL] [Abstract][Full Text] [Related]
4. Chronic cholestasis associated with Turner's syndrome: 12 years of clinical and histopathological follow-up.
Wardi J; Knobel B; Shahmurov M; Melamud E; Avni Y; Shirin H
Digestion; 2003; 67(1-2):96-9. PubMed ID: 12743447
[TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya P; Lindor KD
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
[No Abstract] [Full Text] [Related]
6. Liver injury from endoscopic insertion of self-expandable metallic stent to relieve biliary obstruction: a fatal complication.
Akaraviputh T; Iramaneerat C; Trakarnsanga A
Gastrointest Endosc; 2009 Sep; 70(3):554; discussion 555. PubMed ID: 19559430
[No Abstract] [Full Text] [Related]
7. Choledocholithiasis at the hepatic confluence mimicking a hilar cholangiocarcinoma.
Läuffer JM; Baer HU; Schajor M; Halter F; Büchler MW
Hepatogastroenterology; 1998; 45(24):2339-43. PubMed ID: 9951919
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
Golovanova EV; Petrakov AV
Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
[TBL] [Abstract][Full Text] [Related]
9. Bile duct wall metastasis from micropapillary variant transitional cell carcinoma of the urinary bladder mimicking primary hilar cholangiocarcinoma.
Hong SP; Park SW; Lee SJ; Chung JP; Song SY; Chung JB; Kang JK; Cho NH
Gastrointest Endosc; 2002 Nov; 56(5):756-60. PubMed ID: 12397294
[No Abstract] [Full Text] [Related]
10. Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.
Perdue DG; Cass OW; Milla C; Dunitz J; Jessurun J; Sharp HL; Schwarzenberg SJ
Dig Dis Sci; 2007 Oct; 52(10):2638-42. PubMed ID: 17443409
[No Abstract] [Full Text] [Related]
11. [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid].
Sciumè C; Geraci G; Pisello F; Facella T; Li Volsi F; Modica G
Chir Ital; 2004; 56(6):831-7. PubMed ID: 15771038
[TBL] [Abstract][Full Text] [Related]
12. Management of an unclear bile duct stenosis.
Langwieler TE; Kim JS; Mann O; Thonke F; Knoefel WT; Rogiers X; Izbicki JR
Surg Endosc; 2004 Apr; 18(4):717-8. PubMed ID: 15214372
[TBL] [Abstract][Full Text] [Related]
13. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
14. [55-year-old woman with icterus].
Regimbeau JM
J Chir (Paris); 2000 Jun; 137(3):176-9. PubMed ID: 10915986
[No Abstract] [Full Text] [Related]
15. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
17. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien CB; Shields DS; Saul SH; Reddy KR
Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
[No Abstract] [Full Text] [Related]
19. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
Lee SJ; Lee YS; Lee MG; Lee SH; Shin E; Hwang JH
Gut Liver; 2014 Nov; 8(6):669-73. PubMed ID: 25368755
[TBL] [Abstract][Full Text] [Related]
20. Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy.
Dunn JM; McNair A
World J Gastroenterol; 2007 Dec; 13(46):6277-80. PubMed ID: 18069774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
